Histamine protects against the acute phase of experimentally-induced hepatic ischemia/re-perfusion

References

• Adachi, N. 2002. Cerebral ischemia and histamine. Nihon Yakurigaku Zasshi 120:215–221.
   PubMedGoogle Scholar
• Adachi, N., Liu, K., Motoki, A., Nishibori, M. Arai, T. 2006. Suppression of ischemia/re-perfusion liver injury by histamine H4 receptor stimulation in rats. Eur. J. Pharmacol. 544:181–187.
   PubMed Web of Science ®Google Scholar
• Adachi, N., Seyfried, F. J. Arai, T. 2001. Blockade of central histaminergic H2 receptors aggravates ischemic neuronal damage in gebril hippocampus. Crit. Care Med. 29:1189–1194.
   PubMed Web of Science ®Google Scholar
• Bailey, S. M. Reinke, L. A. 2000. Antioxidants and gadolinium chloride attenuate hepatic parenchymal and endothelial cell injury induced by low flow ischemia and re-perfusion in perfused rat livers. Free Rad. Res. 32:497–506.
   PubMed Web of Science ®Google Scholar
• Bremer, C., Bradford, B. U., Hunt, K. J., Knecht, K. T., Connor, H. D., Mason, R. P. Thurman, R. G. 1994. Role of Kupffer cells in the pathogenesis of hepatic re-perfusion injury. Am. J. Physiol. 267:G630–636.
   Google Scholar
• Colletti, L. M., Cortis, A., Lukacs, N., Kunkel, S. L., Green, M. Strieter, R. M. 1998. Tumor necrosis factor up-regulates inracellular adhesion molecule-1, which is important in neutrophil-dependent lung and liver injury associated with hepatic ischemia and re-perfusion in the rat. Shock 10:182–191.
   PubMed Web of Science ®Google Scholar
• Colletti, L. M., Kunkel, S. L., Walz, A., Burdick, M. D., Kunkel, R. G., Wilke, C. A. Strieter, R. M. 1996. The role of cytokine networks in the local liver injury following hepatic ischemia/re-perfusion in the rat. Hepatology 23:506–514.
   PubMed Web of Science ®Google Scholar
• Colletti, L. M., Remick, D. G., Burtch, G. D., Kunkel, S. L., Strieter, R. M. Campbell, D. A. Jr. 1990. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia re-perfusion injury in the rat. J. Clin. Invest. 85:1936–1943.
   PubMed Web of Science ®Google Scholar
• Dy, M. Schneider, E. 2004. Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev. 15:393–410.
   PubMed Web of Science ®Google Scholar
• Elenkov, I. J., Webster, E., Papanicolaou, D. A., Fleisher, T. A., Chrousos, G. P. Wilder, R. L. 1998. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161:2586–2593.
   PubMed Web of Science ®Google Scholar
• Ellman, G. L. 1959. Tissue sulfahydryl groups.. Arch. Biochem. Biophys 82:70–77.
   PubMed Web of Science ®Google Scholar
• Gschwandtner, M., Schäkel, K., Werfel, T. Gutzmer, R. 2011. Histamine H4 receptor activation on human slan-dendritic cells down-regulates their pro-inflammatory capacity. Immunology 132:49–56
   PubMed Web of Science ®Google Scholar
• Gutzmer, R., Diestel, C., Mommert, S., Köther, B., Stark, H., Wittmann, M. Werfel, T. 2005. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J. Immunol. 174:5224–5232.
   PubMed Web of Science ®Google Scholar
• Hilkens, C. M., Kalinski, P., de Boer, M. Kapsenberg, M. L. 1997. Human dendritic cells require exogenous IL-12-inducing factors to direct the development of naive T-helper cells toward the TH1 phenotype. Blood 90:1920–1926.
   PubMed Web of Science ®Google Scholar
• Hirasawa, N., Ohuchi, K., Watanabe, M. Tsurufuji, S. 1987. Role of endogenous histamine in post-anaphylactic phase of allergic inflammation in rats. J. Pharmacol. Exp. Ther. 241:967–973.
   PubMed Web of Science ®Google Scholar
• Hisama, N., Yamaguchi, Y., Ishiko, T., Miyanari, N., Ichiguchi, O., Goto, M., Mori, K., Watanabe, K., Kawamura, K., Tsurufuji, S., and Ogawa, M. 1996. Kupffer cell production of cytokine-induced. neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 24:1193–1198.
   PubMed Web of Science ®Google Scholar
• Hofstra, C. L., Desai, P. J., Thurmond, R. L. Fung-Leung, W. P. 2003. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305:1212–1221.
   PubMed Web of Science ®Google Scholar
• Jaeschke, H. Farhood, A. and Smith, C. W. 1990. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. Faseb J 4:3355–3359.
   PubMed Web of Science ®Google Scholar
• Jaeschke, H. Farhood, A. 1991. Neutrophil and Kupffer cell-induced oxidant stress and ischemia/re-perfusion injury in rat liver. Am. J. Physiol. 260:G355–362.
   PubMed Web of Science ®Google Scholar
• Jaeschke, H., Bautista, A. P., Spolarics, Z., and Spitzer, J. J. 1991. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic. Res. commun 15:277–284.
   PubMed Web of Science ®Google Scholar
• Jaeschke, H. 1998. Mechanisms of reperfusion injury after warm ischemia of the liver. J. Hepatobiliary Pancreat. Surg 5:402–408.
   PubMedGoogle Scholar
• Köken, T., Serteser, M., Kahraman, A., Akbulut, G. Dilek, O. N. 2004. Which is more effective in the prevention of renal ischemia-re-perfusion-induced oxidative injury in the early period in mice: Interleukin (IL)-10 or anti-IL-12? Clin. Biochem. 37:50–55.
   PubMed Web of Science ®Google Scholar
• Lentsch, A. B., Yoshidome, H., Kato, A., Warner, R. L., Cheadle, W. G., Ward, P. A. Edwards, M. J. 1999. Requirement for IL-12 in pathogenesis of warm hepatic ischemia/re-perfusion injury in mice. Hepatology 30:1448–1453.
   PubMed Web of Science ®Google Scholar
• Ling, P., Ngo, K., Nguyen, S., Thurmond, R. L., Edwards, J. P., Karlsson, L. Fung-Leung, W. P. 2004. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br. J. Pharmacol. 142:161–171.
   PubMed Web of Science ®Google Scholar
• Martinez-Mier, G., Toledo-Pereyra, L. H., and Ward, P. A. 2000. Adhesion molecules in liver ischemia and reperfusion. J. Surg. Res 94:185–194.
   PubMed Web of Science ®Google Scholar
• Matsushita, T., Ando, K., Kimura, K., Ohnishi, H., Imawari, M., Muto, Y. Moriwaki, H. 1999. IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. Int. Immunol. 11:657–665.
   PubMed Web of Science ®Google Scholar
• Motoki, A., Adachi, N., Liu, K., Takahashi, H. K., Nishibori, M., Yorozuya, T., Arai, T. Nagaro, T. 2008. Suppression of ischemia-induced cytokine release by dimaprit and amelioration of liver injury in rats. Basic Clin. Pharmacol. Toxicol. 102:394–398.
   PubMed Web of Science ®Google Scholar
• Myers, K. J., Eppihimer, M. J., Hall, L. Wolitzky, B. 1998. IL-12-induced adhesion molecule expression in murine liver. Am. J. Pathol. 152:457–468.
   PubMed Web of Science ®Google Scholar
• Nakamura, T., Itadani, H., Hidaka, Y., Ohta, M. Tanaka, K. 2000. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem. Biophys. Res. Commun. 279:615–620.
   PubMed Web of Science ®Google Scholar
• Nardo, B., Caraceni, P., Pasini, P., Domenicali, M., Catena, F., Cavallari, G., Santoni, B., Maiolini, E., Grattagliano, I., Vendemiale, G., Trevisani, F., Roda, A., Bernardi, M. Cavallari, A. 2001. Increased generation of reactive oxygen species in isolated rat fatty liver during postischemic reoxygenation. Transplantation 71:1816–1820.
   PubMed Web of Science ®Google Scholar
• Packard, K. A. Khan, M. M. 2003. Effects of histamine on TH1/TH2 cytokine balance. Int. Immunopharmacol. 3:909–920.
   PubMed Web of Science ®Google Scholar
• Reitman, S. and, Frankel, S. A. 1957. The determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am. J. Clin. Path 28:56–63.
   PubMed Web of Science ®Google Scholar
• Rudiger, H. A. Clavien, P. A. 2002. Tumor necrosis factor-α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 122:202–210.
   PubMed Web of Science ®Google Scholar
• Scales, W. E., Campbell, D. A., Green, M. E. Jr., and Remick, D. G. 1994. Hepatic ischemia/re-perfusion injury: Importance of oxidant/tumor necrosis factor interactions. Am. J. Physiol. 267:G1122–1127.
   Google Scholar
• Seo, M. Y. Lee, S. M. 2002. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/re-perfusion in rats. J. Hepatol. 36:72–77.
   PubMed Web of Science ®Google Scholar
• Shiratori, Y., Kiriyama, H., Fukushi, Y., Nagura, T., Takada, H., Hai, K. Kamii, K. 1994. Modulation of ischemia/re-perfusion-induced hepatic injury by Kupffer cells. Dig. Dis. Sci. 39:1265–1272.
   PubMed Web of Science ®Google Scholar
• Squadrito, F., Altavilla, D., Squadrito, G., Ferlito, M., Deodato, B., Arlotta, M., Minutoli, L., Campo, G. M., Bova, A., Quartarone, C., Urna, G., Sardella, A., Saitta, A. Caputi, A. P. 2000. Protective effects of cyclosporine-A in splanchnic artery occlusion shock. Br. J. Pharmacol. 130:339–344.
   PubMed Web of Science ®Google Scholar
• Su, J. F., Guo, C. J., Wei, J. Y., Yang, J. J., Jiang, Y. G. Li, Y. F. 2003. Protection against hepatic ischemia-re-perfusion injury in rats by oral pre-treatment with quercetin. Biomed. Environ. Sci. 16:1–8.
   PubMed Web of Science ®Google Scholar
• Sugimoto, K., Abe, K., Lee, T. H., Sakurai, E., Yanai, K., Kogure, K., Itoyama, Y. Watanabe, T. 1994. Histamine depletion in brain caused by treatment with (S) α-fluoro-methylhistidine enhances ischemic damage of gerbil hippocampal CA2 neurons. Brain Res. 66:279–283.
   Google Scholar
• Teoh, N. C., and Farrell, G. C. 2003Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J. Gastroenterol. Hepatol 18:891–902.
   PubMed Web of Science ®Google Scholar
• Togashi, H., Shinzawa, H., Matsuo, T., Takeda, Y., Takahashi, T., Aoyama, M., Oikawa, K. Kamada, H. 2000. Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging. Free Rad. Biol. Med. 28:846–853.
   PubMed Web of Science ®Google Scholar
• Yoshioka, T., Kawada, K., Shimada, T. Mori, M. 1979. Lipid peroxidation in maternal and cord blood and protective mechanism against activated oxygen-toxicity in blood. Am. J. Obstet. Gynecol. 135:372–376.
   PubMed Web of Science ®Google Scholar
• Zisman, D. A., Kunkel, S. L., Strieter, R. M., Gauldie, J., Tsai, W. C., Bramson, J., Wilkowski, J. M., Bucknell, K. A. Standiford, T. J. 1997. Anti-IL-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 8:349–356.
   PubMed Web of Science ®Google Scholar